BioSpace News Archive

In reaction to the dodgy deals that the drug industry is concocting to profit from the COVID 19 pandemic, AIDS Healthcare Foundation (AHF) today called on the U.S. government today to use its patent and “march-in” rights under section 1498 of the U.S. cod

Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on improving the lives of patients who suffer from psychiatric disorders, announced that Keith J. Sullivan has been appointed as the company’s President and Chief Executive Officer and has joined the Board of Directors effective immediately. “The Neuronetics Board of Directors is very happy to complete our rigorous CEO search with the hiring of Keith Sulliva

Cutera, Inc. ( CUTR ) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that Dave Mowry, Chief Executive Officer, will participate in a panel discussion as part of the Re-Engaging Medical Practices in an Era of COVID-19 webinar, presented by Maxim Group and M-Vest, at 11:00 a.m. ET on Thursday, July 16, 2020. The panel di

Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced the closing of its initial public offering of 16,100,000 shares of common stock, including the exercise in full by the underwriters of their option to purchase up to 2,100,000 additional shares of common stock, at a public offering price of $18.00 per share. The aggregate

Empirical Spine, Inc., a Silicon-Valley based medical technology company, announced today that data from the IDE study of the company’s LimiFlex Paraspinous Tension Band for patients suffering from degenerative spondylolisthesis with lumbar spinal stenosis, will be presented at the 27th International Meeting on Advanced Spine Techniques

National architecture, engineering and planning firm Bergmann has launched a new Science, Technology & Industry (STI) practice, providing an in-demand offering to companies in complex technical industries, including pharmaceuticals and biotechnology.

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announces its second quarter fiscal 2020 results. Brian Pedlar, Covalon’s President and CEO, said, “Like all businesses everywhere in the world, Covalon has been severely impacted by the COVID-19 pandemic. In response, the entire Covalon team has been working very hard to generate sa

Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273) Interim analysis of original cohorts of Phase 1 study evaluated two-dose vaccination schedule of mRNA-1273 across three dose levels (25, 100, 250 µg) in 45 healthy adults ages 18-55 years; results reaffirm and expand upon positive interim data announced on May 18 th Neutralizing antibody titers we

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) announces the grant of patent no. 10,711,060 entitled “Antibody molecules to LAG-3 and uses thereof” by the United States Patent and Trade Mark Office.

Mid-Delaware Imaging announced that it has taken action after becoming aware of a ransomware event in which an unknown third party encrypted its systems.